DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Elimite is a drug marketed by Mylan and is included in one NDA.
The generic ingredient in ELIMITE is permethrin. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the permethrin profile page.
A generic version of ELIMITE was approved as permethrin by ACTAVIS LABS on January 23rd, 1998.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Mylan||ELIMITE||permethrin||CREAM;TOPICAL||019855-001||Aug 25, 1989||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|